(S)-N-((S)-1-((2-Cyclopropylethyl)amino)-5-guanidino-1-oxopentan-2-yl)-1-((1R,2R)-2-((R)-((S)-1-(4-((3',4'-dichloro-[1,1'-biphenyl]-3-yl)amino)-4-oxobutanoyl)pyrrolidin-2-yl)(hydroxy)methyl)cyclopentanecarbonyl)pyrrolidine-2-carboxamide

ID: ALA5202610

Chembl Id: CHEMBL5202610

PubChem CID: 168293052

Max Phase: Preclinical

Molecular Formula: C43H58Cl2N8O6

Molecular Weight: 853.89

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCC[C@H]1[C@@H](O)[C@@H]1CCCN1C(=O)CCC(=O)Nc1cccc(-c2ccc(Cl)c(Cl)c2)c1)C(=O)NCCC1CC1

Standard InChI:  InChI=1S/C43H58Cl2N8O6/c44-32-16-15-28(25-33(32)45)27-6-1-7-29(24-27)50-37(54)17-18-38(55)52-22-4-11-35(52)39(56)30-8-2-9-31(30)42(59)53-23-5-12-36(53)41(58)51-34(10-3-20-49-43(46)47)40(57)48-21-19-26-13-14-26/h1,6-7,15-16,24-26,30-31,34-36,39,56H,2-5,8-14,17-23H2,(H,48,57)(H,50,54)(H,51,58)(H4,46,47,49)/t30-,31-,34+,35+,36+,39-/m1/s1

Standard InChI Key:  UHNFOGWZTKRPGW-IKIDTFQCSA-N

Alternative Forms

  1. Parent:

    ALA5202610

    ---

Associated Targets(Human)

NCF1 Tbio Neutrophil cytosol factor 1 (245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 853.89Molecular Weight (Monoisotopic): 852.3856AlogP: 4.80#Rotatable Bonds: 18
Polar Surface Area: 210.05Molecular Species: BASEHBA: 7HBD: 7
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.51CX Basic pKa: 11.86CX LogP: 2.79CX LogD: 0.70
Aromatic Rings: 2Heavy Atoms: 59QED Weighted: 0.06Np Likeness Score: -0.55

References

1. Garsi JB, Komjáti B, Cullia G, Fejes I, Sipos M, Sipos Z, Fördős E, Markacz P, Balázs B, Lancelot N, Berger S, Raimbaud E, Brown D, Vuillard LM, Haberkorn L, Cukier C, Szlávik Z, Hanessian S..  (2022)  Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics.,  13  (6.0): [PMID:35707140] [10.1021/acsmedchemlett.2c00094]

Source